((((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)(HYDROXY)PHOSPHORYL)OXY)METHYL ISOPROPYL CARBONATE(CAS: 211364-69-1)

Mono-poc tenofovir (CAS: 211364-69-1) is subject to various regulatory guidelines including the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH registration for European manufacturers, and FDA/EPA requirements for pharmaceutical use. Compliance with these regulations is necessary for safe handling, storage, and distribution.

Alternatives to Mono-poc tenofovir (CAS: 211364-69-1) in synthesis include other antiretroviral agents such as tenofovir disoproxil fumarate and tenofovir alafenamide, which may offer similar antiviral activity with different chemical structures and synthesis routes.

The market for Mono-poc tenofovir (CAS: 211364-69-1) shows increasing demand as it is a key component in antiretroviral therapy for HIV. Research trends focus on its efficacy, safety, and potential in combination therapies, as well as the development of more stable and bioavailable forms.

Waste containing Mono-poc tenofovir (CAS: 211364-69-1) should be collected in appropriate containers, labeled with the correct hazardous waste symbols, and disposed of through professional waste disposal services. Proper incineration or chemical treatment methods should be employed to ensure environmental safety and compliance with local regulations.